go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

Ricesteele Manufacturing Ltd

Ricesteele Manufacturing Ltd
Unit 31, Cookstown Industrial Estate, Tallaght, Dublin 24,
Telephone: +353 1 451 0144
Fax: +353 1 452 1875


Summary of Product Characteristics last updated on medicines.ie: 23/08/2007
SPC Pedamed 100mg/g Cutaneous Powder

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipient(s)
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Pedamed 100mg/g Cutaneous Powder


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each gram of powder contains 100 mg zinc undecylenate equivalent to zinc undecylenate 10% w/w.

For a full list of excipients, see section 6.1.


Go to top of the page
3. PHARMACEUTICAL FORM

Cutaneous powder.

Fine, white powder.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

For the prevention of athlete's foot and other fungal skin infections.

For the elimination of foot odours and antiperspirant effect.


Go to top of the page
4.2 Posology and method of administration

After cleansing and drying the affected area, Pedamed Powder should be applied twice daily and rubbed in gently. For optimum effectiveness the powder should be used with an appropriate anti-fungal cream. Treatment should be continued for one week after all signs of infection have disappeared.


Go to top of the page
4.3 Contraindications

Known hypersensitivity to any of the ingredients.


Go to top of the page
4.4 Special warnings and precautions for use

Do not use on broken skin.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known.


Go to top of the page
4.6 Pregnancy and lactation

No information available.


Go to top of the page
4.7 Effects on ability to drive and use machines

None known.


Go to top of the page
4.8 Undesirable effects

Skin irritation can occur occasionally to some of the ingredients. If this occurs, use of the product should be discontinued.


Go to top of the page
4.9 Overdose

Not applicable.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Zinc Undecylenate is an anti-fungal agent.


Go to top of the page
5.2 Pharmacokinetic properties

No information given.


Go to top of the page
5.3 Preclinical safety data

No information given.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipient(s)

Zinc Oxide

Alum

Allantoin

Chlorhexidine Hydrochloride

Levomenthol

Talc

Maize Starch.


Go to top of the page
6.2 Incompatibilities

Not applicable.


Go to top of the page
6.3 Shelf life

3 years


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.

Keep the container tightly closed.


Go to top of the page
6.5 Nature and contents of container

Multidose, well-closed, sifter-top container composed of HDPE. Contains 65g of Pedamed 100 mg/g Cutaneous Powder.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Ricesteele Manufacturing Ltd,

Cookstown Industrial Estate,

Tallaght,

Dublin 24.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

P.A. 95/12/2


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

26th August 1986/ 26th August 2006.


Go to top of the page
10. DATE OF REVISION OF THE TEXT

October 2006



Link to this document from your website:
http://www.medicines.ie/medicine/2726/SPC/Pedamed+100mg+g+Cutaneous+Powder/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Active Ingredients

 
   Zinc undecylenate

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo